Intervention for Respiratory Failure

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Johns Hopkins All Children's Hospital, Saint Petersburg, FL
Respiratory Failure+1 More
Structured Family Deliberation - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study seeks to evaluate a Structured Family Deliberation that will serve as the primary intervention in a multicenter controlled trial involving families considering tracheostomy and home ventilation for the child. In this study, the investigators will evaluate the feasibility, usefulness, face validity, and preliminary impact of this approach on preparedness for decision making among participants.

Eligible Conditions

  • Respiratory Failure
  • Chronic Respiratory Failure

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Respiratory Failure

Study Objectives

3 Primary · 6 Secondary · Reporting Duration: Duration of study period (12 months)

Day 30
Face validity of the Structured Family Deliberation Process will be assessed by participant responses to qualitative interview questions
Factors in decision making as assessed by participants responses to qualitative interview questions
Feasibility as assessed by time spent engaging with the website by parents
Parental distress as assessed by the "parental distress" items on the The Parental Stress and Coping Inventory
Parental stress and coping as assessed by participants responses to qualitative interview
Preparedness in decision making as assessed by Preparation for Decision-Making Scale
Usefulness of the Structured Family Deliberation Process will be assessed by participant responses to qualitative interview questions
Month 12
Feasibility as assessed by proportion of families enrolled
Feasibility as assessed by proportion of successfully completed interventions

Trial Safety

Safety Progress

1 of 3

Other trials for Respiratory Failure

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

15 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Intervention
Other
Experimental Group · 1 Intervention: Structured Family Deliberation · Intervention Types: Other
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: duration of study period (12 months)
Closest Location: Johns Hopkins All Children's Hospital · Saint Petersburg, FL
2018First Recorded Clinical Trial
0 TrialsResearching Respiratory Failure
48 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.